EUROPEAN COMMISSION

DG Competition

Only the English text is available and authentic.

REGULATION (EC) No 139/2004

MERGER PROCEDURE

Article 6(1)(b) NON-OPPOSITION

Date: 11/03/2024

In electronic form on the EUR-Lex website under document number 32024M11402

EUROPEAN COMMISSION

Brussels, 11.3.2024 C(2024) 1740 final

PUBLIC VERSION

BNP Paribas SA 12 rue Chauchat 75009 Paris France

Dear Sir or Madam,

(1) On 16 February 2024, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation, by which BNP Paribas Cardif S.A. (“BNPP Cardif”, France), controlled by BNP Paribas S.A., will acquire, within the meaning of Article 3(1)(b) of the Merger Regulation, sole control of the whole of BCC Vita S.p.A. (“BCC Vita”, Italy), controlled by ICCREA Banca S.p.A. (“ICCREA”, Italy). The concentration is accomplished by way of purchase of 3shares. ()

(2) The business activities of the undertakings concerned are the following:

– BNPP Cardif designs, develops, and markets savings and protection offers to insure people, their projects and their assets,

– BCC Vita is active in the provision of life insurance products in Italy.

(3) After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(d) of the Commission Notice on a simplified treatment for certain 4concentrations under Council Regulation (EC) No 139/2004. ()

1() OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology of the TFEU will be used throughout this decision.

2() OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).

3() OJ C, C/2024/1749, 26.2.2024.

4() OJ C 160, 5.5.2023, p. 1 (the ‘Notice on a simplified treatment’). Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË – Tel. +32 22991111

2

(4) For the reasons set out in the Notice on a simplified treatment, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement.

For the Commission

(Signed) Olivier GUERSENT Director-General

11